Geoffrey Beran Rose - 01 Sep 2023 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Chief Commercial Officer
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Geoffrey Beran Rose
Issuer symbol
LUNG
Transactions as of
01 Sep 2023
Net transactions value
-$28,458
Form type
4
Filing time
06 Sep 2023, 18:03:22 UTC
Previous filing
25 Aug 2023
Next filing
26 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $3,934 -393 -0.15% $10.01 255,471 01 Sep 2023 Direct F1
transaction LUNG Common Stock Sale $6,917 -691 -0.27% $10.01 254,780 01 Sep 2023 Direct F2
transaction LUNG Common Stock Sale $17,608 -1,759 -0.69% $10.01 253,021 01 Sep 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.